GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0015701 |
bicarbonate transport
|
CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
12.2004 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
11.4042 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADORA2A, AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, FLT3, HCAR2, KDR, MET, MMP12, MMP9, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
8.87971 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADORA2A, AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, FLT3, HCAR2, KDR, MET, MMP12, MMP9, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
8.87971 |
[BP] GO:0042221 |
response to chemical
|
ABCB1, ADORA2A, AKR1B1, ALOX15, ALPL, APP, AXL, BCL2, CA2, CA3, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, EPHX2, FABP3, FABP4, FLT3, IGF1R, KDR, MMP2, MMP9, PPARA, RORC, SRC, TERT |
8.12929 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4, KDR, MMP9, SRC, TERT |
7.86048 |
[BP] GO:0044281 |
small molecule metabolic process
|
ADORA2A, AKR1B1, AKR1B10, ALOX15, ALOX5, APP, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EPHX2, FABP3, PIM1, PPARA, XDH |
7.73671 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, ADORA2A, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APP, AURKB, AXL, BACE1, BCL2, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, DYRK1A, EPHX2, FABP3, FABP4, FLT3, HSD17B1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, PTPRS, RORC, SRC, TERT, TNKS, TNKS2, XDH |
7.73671 |
[BP] GO:0015711 |
organic anion transport
|
ABCB1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, FABP3, PPARA |
7.42061 |
[BP] GO:0010033 |
response to organic substance
|
ADORA2A, AKR1B1, ALOX15, ALPL, APP, AXL, BCL2, CA2, CA3, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, FABP3, FABP4, FLT3, IGF1R, KDR, MMP2, PPARA, RORC, SRC |
7.24758 |
[BP] GO:0048518 |
positive regulation of biological process
|
ABCB1, ACHE, ADORA1, ADORA2A, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DRD1, DRD2, DYRK1A, EPHX2, FABP3, FABP4, FLT3, HCAR2, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
7.06981 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, ADORA2A, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APP, AURKB, AXL, BACE1, BCL2, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, DYRK1A, EPHX2, FABP3, FABP4, FLT3, HSD17B1, IGF1R, KDR, MET, MMP1, MMP2, PIM1, PPARA, PTPN1, PTPRS, RORC, SRC, TERT, TNKS, TNKS2, XDH |
7.00072 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APP, AXL, BCL2, CA3, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, FABP3, IGF1R, MMP2, MMP9, PPARA, RORC, SRC |
6.94259 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ADORA2A, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CA3, CDC25B, CSNK2A1, DRD1, DRD2, DYRK1A, EPHX2, FLT3, IGF1R, KDR, MET, PIM1, PTPN1, PTPRS, SRC, TNKS, XDH |
6.71002 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADORA2A, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DRD1, DRD2, DYRK1A, FABP3, FLT3, HCAR2, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
6.69802 |
[BP] GO:0009636 |
response to toxic substance
|
ADORA2A, AKR1B1, ALPL, AXL, BCL2, CA3, CYP1A1, CYP1B1, DRD1, DRD2, EPHX2, KDR, SRC |
6.67725 |
[BP] GO:0065008 |
regulation of biological quality
|
ABCB1, ACHE, ADORA1, ADORA2A, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, EPHX2, FABP3, FABP4, FLT3, HCAR2, HSD17B1, KDR, MET, PPARA, SRC, TERT, TNKS, TNKS2, XDH |
6.67017 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, APP, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, EPHX2, FABP3, FABP4, HSD17B1, MET, PPARA |
6.64726 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADORA2A, AKR1B1, ALOX15, APP, AURKB, AXL, BACE1, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DYRK1A, FLT3, HCAR2, IGF1R, KDR, MET, MMP12, MMP9, PTPN1, PTPRS, SRC, TERT, TNKS, TNKS2, XDH |
6.59986 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADORA2A, AKR1B1, ALOX15, APP, AURKB, AXL, BACE1, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DYRK1A, FLT3, HCAR2, IGF1R, KDR, MET, MMP12, MMP9, PTPN1, PTPRS, SRC, TERT, TNKS, TNKS2, XDH |
6.47686 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ADORA2A, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CA3, CDC25B, CSNK2A1, DRD1, DRD2, DYRK1A, EPHX2, FLT3, IGF1R, KDR, MET, PIM1, PTPN1, PTPRS, SRC, TNKS, XDH |
6.42157 |
[BP] GO:0006820 |
anion transport
|
ABCB1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, FABP3, PPARA |
6.19733 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA2A, ADORA3, AKR1B1, APP, BCL2, CDC25B, CSNK2A1, CYP1B1, DNMT1, DRD2, FABP3, FLT3, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, SRC, TERT, XDH |
6.02256 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, ADORA2A, AURKB, BCL2, CA2, CA7, DRD1, DRD2, HCAR2, KDR, SRC, TNKS, TNKS2 |
5.91541 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADORA2A, AKR1B1, ALOX15, APP, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, FLT3, KDR, MET, MMP12, MMP9, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
5.84433 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ADORA2A, ALPL, APP, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, FLT3, RORC, SRC |
5.59307 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALOX15, ALPL, APP, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, FABP4, FLT3, IGF1R, KDR, MMP2, MMP9, RORC, SRC, TERT |
5.21147 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1 |
5.17995 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, ADORA2A, BCL2, CA2, CA7, DRD1, DRD2, KDR, SRC |
5.07559 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, EPHX2 |
5.06036 |
[BP] GO:0032879 |
regulation of localization
|
ABCB1, ACHE, ADORA1, ADORA2A, ADORA3, ALOX15, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, HCAR2, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTPN1, SRC, TERT |
5.01388 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, EPHX2 |
4.98223 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, ADORA2A, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SRC, TERT |
4.96683 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
ADORA2A, AURKB, CA2, CA7, DRD1, DRD2, HCAR2, TNKS, TNKS2 |
4.81611 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, EPHX2 |
4.80545 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, ADORA2A, AKR1B1, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CA2, CA9, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DYRK1A, FABP4, FLT3, KDR, MET, MMP2, MMP9, PIM1, PPARA, PTPRS, RORC, SRC, TERT, TNKS2 |
4.80545 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, APP, BCL2, CA2, CA9, CSNK2A1, CYP1A2, DNMT1, DRD1, FABP3, FLT3, IGF1R, MMP2, PPARA, SRC |
4.80545 |
[BP] GO:0042493 |
response to drug
|
ABCB1, ADORA2A, AKR1B1, AXL, BCL2, CA3, CA9, CYP1A1, CYP1B1, DRD1, DRD2, FABP3, KDR, SRC |
4.73072 |
[BP] GO:0050896 |
response to stimulus
|
ABCB1, ACHE, ADORA1, ADORA2A, ADORA3, AKR1B1, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CA2, CA3, CA6, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, EPHX2, FABP3, FABP4, FLT3, IGF1R, KDR, MMP12, MMP2, MMP9, PPARA, PTPN1, RORC, SRC, TERT |
4.73072 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, ADORA2A, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SRC, TERT |
4.70633 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, ADORA2A, CA2, CA7, DRD2 |
4.70633 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, APP, BCL2, CA2, CYP1A1, CYP1A2, DRD2, FABP4, MMP9, TERT |
4.70049 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADORA2A, AKR1B1, ALOX15, APP, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, FABP4, FLT3, KDR, MET, MMP12, MMP2, MMP9, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
4.67228 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, ADORA2A, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, FLT3, HCAR2, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SRC, TERT, XDH |
4.66926 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA2A, ADORA3, APP, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, IGF1R, KDR, MET, MMP9, SRC, TERT |
4.6006 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, IGF1R, KDR, MET, MMP9, SRC, TERT |
4.52651 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, ADORA2A, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, FLT3, HCAR2, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SRC, TERT, XDH |
4.47388 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, ADORA2A, APP, CA2, CA7, DRD1, DRD2 |
4.45596 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADORA2A, ALOX15, APP, AURKB, BCL2, CDC25B, CSNK2A1, DNMT1, DRD1, DRD2, DYRK1A, EPHX2, FABP3, FLT3, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
4.43976 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALOX15, ALPL, APP, AXL, BCL2, CYP1A1, CYP1B1, DNMT1, DRD1, FABP4, FLT3, IGF1R, KDR, MMP2, RORC, SRC |
4.4194 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.39153 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD1, DYRK1A, FLT3, IGF1R, KDR, MET, PIM1, SRC, TNKS |
4.36818 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA2A, ADORA3, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DNMT1, DRD1, DRD2, DYRK1A, FABP3, FABP4, HCAR2, IGF1R, KDR, MET, MMP12, MMP9, PIM1, PPARA, PTPN1, PTPRS, RORC, SRC, TERT, TNKS, TNKS2, XDH |
4.29227 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, PIM1, SRC |
4.26956 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ABCB1, ADORA1, ADORA2A, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DYRK1A, FABP4, FLT3, IGF1R, KDR, MET, MMP12, MMP2, MMP9, PPARA, PTPN1, PTPRS, SRC, TERT, TNKS, TNKS2, XDH |
4.26956 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADORA2A, ALOX15, APP, AURKB, BCL2, CDC25B, CSNK2A1, DNMT1, DRD1, DRD2, DYRK1A, FLT3, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
4.26403 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, IGF1R, KDR, MET, MMP9, SRC, TERT |
4.26403 |
[BP] GO:0051050 |
positive regulation of transport
|
ABCB1, ACHE, ADORA1, ADORA2A, APP, AXL, BCL2, CA2, CYP19A1, DRD1, DRD2, HCAR2, MMP12, SRC, TERT |
4.24941 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX15, ALOX5, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, EPHX2, FABP3, FABP4, MET, PPARA |
4.24941 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC, TERT |
4.15724 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA2A, ADORA3, AKR1B1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DNMT1, DRD1, DRD2, DYRK1A, FABP3, FABP4, IGF1R, KDR, MET, MMP12, MMP9, PIM1, PPARA, PTPN1, PTPRS, RORC, SRC, TERT, TNKS, TNKS2, XDH |
4.10127 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, ADORA2A, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, IGF1R, KDR, MMP9, PIM1, PTPN1, SRC, TERT |
4.09706 |
[BP] GO:0080134 |
regulation of response to stress
|
ABCB1, ADORA1, ADORA2A, APP, CYP19A1, DRD2, DYRK1A, FABP4, IGF1R, MET, MMP12, MMP2, PPARA, PTPN1, PTPRS, SRC, TERT, XDH |
4.09706 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADORA2A, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APP, AXL, BCL2, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, EPHX2, FABP4, IGF1R, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, RORC, SRC, TNKS2 |
4.07252 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, EPHX2, FABP3, PPARA |
4.0491 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADORA2A, ALOX15, BCL2, CYP19A1, DRD1, DRD2, DYRK1A, IGF1R, MET, MMP12, MMP9, PPARA, PTPN1, PTPRS, SRC, TERT, XDH |
4.01406 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA2A, ADORA3, APP, AURKB, CSNK2A1, CYP1B1, DRD2, FABP4, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC, TNKS |
4.01406 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, ADORA2A, APP, BACE1, CA2, CA7, DRD1, DRD2 |
4.01406 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, ADORA2A, APP, BACE1, CA2, CA7, DRD1, DRD2 |
4.01406 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADORA2A, ALOX15, APP, AURKB, BCL2, CDC25B, DNMT1, DRD1, DRD2, DYRK1A, FABP3, FLT3, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
4.01406 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, FABP4, FLT3, IGF1R, KDR, MMP2, MMP9, PTPN1, RORC, SRC, TERT |
3.98009 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ALOX15, APP, AURKB, BCL2, CDC25B, CSNK2A1, DNMT1, DRD1, DRD2, DYRK1A, EPHX2, FLT3, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
3.97917 |
[BP] GO:0051049 |
regulation of transport
|
ABCB1, ACHE, ADORA1, ADORA2A, ALOX15, APP, AXL, BCL2, CA2, CA7, CYP19A1, DRD1, DRD2, HCAR2, MMP12, MMP9, PPARA, PTPN1, SRC, TERT |
3.9718 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, ADORA2A, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, FLT3, HCAR2, IGF1R, KDR, MMP9, PIM1, PTPN1, SRC, TERT, XDH |
3.9718 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, IGF1R, KDR, MET, MMP9, SRC, TERT |
3.93246 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, EPHX2 |
3.91184 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, EPHX2 |
3.89768 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, APP, AXL, BCL2, CA12, CA2, CA7, DRD1, DRD2, EPHX2, FABP3, FABP4, FLT3, MET, SRC, TERT |
3.89588 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, ALOX15, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2 |
3.88564 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, EPHX2 |
3.80579 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD17B1 |
3.67127 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADORA2A, ALOX15, APP, BCL2, CDC25B, DRD1, DRD2, FABP3, FLT3, KDR, MMP9, PTPN1, SRC, XDH |
3.65436 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADORA2A, ALOX15, APP, BCL2, CDC25B, DRD1, DRD2, FABP3, FLT3, KDR, MMP9, PTPN1, SRC, XDH |
3.65436 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC, TERT, TNKS |
3.63264 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, ADORA2A, AKR1B1, ALOX15, ALPL, APP, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DYRK1A, FLT3, KDR, MMP9, PIM1, PPARA, PTPRS, RORC, SRC |
3.63264 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, ALOX15, APP, AXL, BCL2, CYP1B1, DRD2, FLT3, KDR, MET, PTPN1, SRC, XDH |
3.55213 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, DRD2, MMP2, PPARA, SRC, TERT |
3.55213 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, BCL2, CYP1A1, DRD2, PPARA |
3.55034 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DYRK1A, FLT3, IGF1R, KDR, MET, MMP9, PTPN1, SRC, XDH |
3.53892 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, ADORA2A, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APP, AURKB, AXL, BACE1, BCL2, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, DYRK1A, EPHX2, FABP3, FABP4, FLT3, HSD17B1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, PTPRS, RORC, SRC, TERT, TNKS, TNKS2, XDH |
3.50805 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AURKB, BACE1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EPHX2, FABP3, FABP4, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
3.49743 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, MMP2, PPARA, SRC, TERT |
3.48219 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CYP1A1, EPHX2, FABP3, FLT3, HCAR2, PPARA, RORC, SRC |
3.4777 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD1, DYRK1A, FLT3, IGF1R, KDR, MET, PIM1, SRC, TNKS |
3.47545 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, DYRK1A, FLT3, IGF1R, KDR, MET, SRC |
3.47545 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, FABP3, FLT3, RORC, SRC |
3.45317 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADORA2A, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DYRK1A, FLT3, IGF1R, KDR, MET, MMP12, MMP9, PTPN1, PTPRS, SRC, TERT, TNKS, TNKS2, XDH |
3.44601 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, DYRK1A, FLT3, IGF1R, KDR, MET, SRC |
3.44063 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADORA2A, ALOX15, APP, BCL2, CDC25B, DRD1, DRD2, FABP4, FLT3, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH |
3.41056 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ALOX15, APP, AURKB, AXL, BCL2, DNMT1, DRD2, IGF1R, KDR, MET, MMP1, MMP9, SRC, TNKS, TNKS2 |
3.40718 |
[BP] GO:0001973 |
None
|
ADORA1, ADORA2A, ADORA3 |
3.37515 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CDC25B, CSNK2A1, DRD2, FLT3, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, TERT |
3.34197 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, DRD2, DYRK1A, PPARA, RORC, SRC |
3.33871 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, ADORA2A, APP, AURKB, BCL2, CSNK2A1, DNMT1, DRD2, DYRK1A, FABP4, HCAR2, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
3.32382 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, MMP2, PPARA, SRC, TERT |
3.26733 |
[BP] GO:0010243 |
response to organonitrogen compound
|
ADORA2A, AKR1B1, APP, DNMT1, DRD1, DRD2, FABP3, FLT3, IGF1R, MMP2, PPARA, SRC |
3.26257 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ADORA2A, ALOX15, APP, BCL2, CDC25B, DRD1, DRD2, FABP4, FLT3, IGF1R, KDR, MMP9, PTPN1, SRC, XDH |
3.26257 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADORA2A, ALOX15, APP, BCL2, CDC25B, DRD1, DRD2, FABP3, FABP4, FLT3, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH |
3.25719 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA2A, ADORA3, AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CA3, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EPHX2, MMP2, MMP9, PPARA, PTPN1, SRC, TERT |
3.25594 |
[BP] GO:2001225 |
regulation of chloride transport
|
ABCB1, CA2, CA7 |
3.25542 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.25542 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, ADORA2A, AKR1B1, CYP19A1, CYP1A1, CYP1B1, DRD2, HCAR2, HSD17B1 |
3.25239 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADORA2A, ALOX15, APP, BCL2, CDC25B, DRD1, DRD2, FABP3, FABP4, FLT3, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH |
3.22432 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ADORA2A, ALOX15, APP, BCL2, CDC25B, DNMT1, DRD1, DRD2, DYRK1A, FABP4, FLT3, IGF1R, KDR, MMP9, PTPN1, SRC, XDH |
3.16133 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, CBR1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EPHX2 |
3.1244 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A2, FABP3, FLT3, PPARA, SRC |
3.09527 |
[BP] GO:0044070 |
regulation of anion transport
|
ABCB1, ADORA1, ADORA2A, CA2, CA7 |
3.06323 |
[BP] GO:0032845 |
None
|
ADORA1, BCL2, DRD2, SRC, TNKS, TNKS2 |
3.06323 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, BCL2, DRD1, DRD2, DYRK1A, IGF1R, MET, MMP12, MMP9, PTPN1, PTPRS, SRC, TERT, XDH |
3.00331 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, BCL2, DRD1, DRD2, DYRK1A, IGF1R, MET, MMP12, MMP9, PTPN1, PTPRS, SRC, TERT, XDH |
2.99005 |
[BP] GO:0009987 |
cellular process
|
ABCB1, ACHE, ADORA1, ADORA2A, ADORA3, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APP, AURKB, AXL, BACE1, BCL2, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, DYRK1A, EPHX2, FABP3, FABP4, FLT3, HCAR2, HSD17B1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, PTPRS, RORC, SRC, TERT, TNKS, TNKS2, TUBB3, XDH |
2.97883 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, ADORA2A, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APP, AURKB, AXL, BACE1, BCL2, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, DYRK1A, EPHX2, FABP3, FABP4, FLT3, HSD17B1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, PTPRS, RORC, SRC, TERT, TNKS, TNKS2, XDH |
2.97883 |
[BP] GO:1901698 |
response to nitrogen compound
|
ADORA2A, AKR1B1, APP, DNMT1, DRD1, DRD2, FABP3, FLT3, IGF1R, MMP2, PPARA, SRC |
2.97751 |
[BP] GO:0006811 |
None
|
ABCB1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD1, DRD2, FABP3, PPARA |
2.94143 |
[BP] GO:0060134 |
None
|
ADORA2A, DRD1, DRD2 |
2.93081 |
[BP] GO:0032230 |
positive regulation of synaptic transmission, GABAergic
|
ADORA2A, CA2, CA7 |
2.93081 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, BCL2, DRD1, IGF1R, KDR, MET, MMP9, SRC, TERT |
2.91437 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, DRD1, DRD2, MMP2, PPARA, SRC, TERT |
2.83369 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APP, AXL, BCL2, CA3, CYP1B1, MMP9, SRC |
2.82266 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, BCL2, DRD1, IGF1R, KDR, MET, MMP9, SRC, TERT |
2.79948 |
[BP] GO:0003014 |
None
|
ADORA1, ADORA2A, AKR1B1, BCL2, DRD2 |
2.77002 |
[BP] GO:0018105 |
peptidyl-serine phosphorylation
|
AURKB, BCL2, DRD1, DYRK1A, SRC, TNKS |
2.76867 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APP, CYP1A1, CYP1B1, DRD1, FLT3, RORC, SRC |
2.76425 |
[BP] GO:0001963 |
None
|
ADORA2A, DRD1, DRD2 |
2.75948 |
[BP] GO:0070198 |
None
|
TERT, TNKS, TNKS2 |
2.75948 |
[BP] GO:0051179 |
None
|
ABCB1, ACHE, ADORA1, ADORA2A, ALOX15, ALOX5, APP, AURKB, AXL, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD1, DRD2, FABP3, MMP12, MMP9, PPARA, SRC, TERT, TNKS, TNKS2, XDH |
2.75706 |
[BP] GO:0042752 |
None
|
ADORA1, ADORA2A, DRD2, PPARA, RORC |
2.74566 |
[BP] GO:0002793 |
None
|
ACHE, ADORA1, ADORA2A, DRD2, HCAR2, MMP12, SRC |
2.73569 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, DRD1, DYRK1A, FLT3, IGF1R, KDR, MET, SRC, TNKS |
2.73569 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, BCL2, DRD1, IGF1R, KDR, MET, MMP9, SRC, TERT |
2.73569 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, ADORA2A, CYP19A1, DRD2, MMP12, PPARA |
2.70758 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ALOX15, APP, BCL2, CDC25B, DNMT1, DRD2, DYRK1A, FLT3, KDR, MMP9, PTPN1, SRC, XDH |
2.69248 |
[BP] GO:0032787 |
None
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, EPHX2, FABP3, PPARA |
2.68811 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
BCL2, CYP1A1, CYP1A2, CYP1B1, EPHX2 |
2.68218 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, BCL2, CYP1B1, MMP9, SRC |
2.67996 |
[BP] GO:0043269 |
regulation of ion transport
|
ABCB1, ADORA1, ADORA2A, APP, BCL2, CA2, CA7, DRD1, DRD2, MMP9 |
2.67996 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APP, AXL, CYP1B1, DNMT1, DRD1, IGF1R, MMP2, MMP9, RORC, SRC |
2.64229 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
ALOX15, AURKB, BCL2, DNMT1, KDR, MET, MMP9, SRC, TNKS, TNKS2 |
2.64229 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, BCL2, DRD1, IGF1R, KDR, MET, MMP9, SRC, TERT |
2.63938 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.63129 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 |
2.61106 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, CSNK2A1, DRD1, DRD2 |
2.58919 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, SRC |
2.58919 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B1 |
2.58919 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, SRC |
2.58919 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
2.58015 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.58009 |
[BP] GO:0051234 |
None
|
ABCB1, ACHE, ADORA1, ADORA2A, ALOX15, ALOX5, APP, AXL, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD1, DRD2, FABP3, MMP12, MMP9, PPARA, SRC, TERT, TNKS, XDH |
2.57598 |
[BP] GO:0018209 |
peptidyl-serine modification
|
AURKB, BCL2, DRD1, DYRK1A, SRC, TNKS |
2.57477 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, ADORA2A, CYP19A1, DRD2, HCAR2, MMP12, SRC |
2.57382 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B1 |
2.56619 |
[BP] GO:0071702 |
None
|
ABCB1, ADORA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD1, DRD2, FABP3, MMP12, PPARA, TNKS |
2.55437 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ADORA2A, ALPL, APP, AXL, BCL2, CBR1, CDC25B, CYP1A1, DRD1, DRD2, FABP4, FLT3, KDR, MET, MMP2, MMP9, PTPRS, RORC, SRC, TERT |
2.55063 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, ADORA2A, CYP19A1, DRD1, DRD2, PPARA, PTPRS |
2.55063 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, ADORA2A, CYP19A1, DRD1, DRD2, FABP4, KDR, MET, MMP12, PPARA, PTPRS |
2.52884 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ALOX15, APP, DRD2, FLT3, KDR, PTPN1, SRC, XDH |
2.5224 |
[BP] GO:0045187 |
None
|
ADORA1, ADORA2A, DRD2 |
2.52205 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.52205 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, ADORA2A, AKR1B1, ALPL, APP, AURKB, AXL, BACE1, BCL2, CDC25B, CSNK2A1, CYP1A1, CYP1A2, DRD1, DRD2, DYRK1A, FLT3, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, PTPRS, SRC, TNKS, TNKS2, XDH |
2.52205 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
ADORA2A, APP, AURKB, BCL2, CSNK2A1, DNMT1, DRD2, DYRK1A, FABP4, IGF1R, MET, MMP12, MMP9, PPARA, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
2.52205 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, ADORA2A, CYP19A1, DRD2, FABP4, MMP12, MMP2, PPARA, PTPN1, PTPRS, SRC |
2.52205 |
[BP] GO:0016311 |
None
|
ALPL, BCL2, CA3, CDC25B, EPHX2, PTPN1, PTPRS |
2.51936 |
[BP] GO:0001503 |
ossification
|
ALOX15, ALPL, BCL2, MMP2, MMP9 |
2.51936 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, EPHX2, RORC |
2.51936 |
[BP] GO:1900673 |
olefin metabolic process
|
CYP1A1, EPHX2 |
2.51704 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.51704 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, APP, BCL2, CA12, CA2, CA7, DRD1, DRD2, EPHX2, FABP3, FABP4, MET |
2.51704 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DRD2, DYRK1A, IGF1R, MET, MMP9, PTPN1, SRC, XDH |
2.5134 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ALOX15, APP, BCL2, CDC25B, DRD2, FLT3, KDR, MMP9, PTPN1, SRC, XDH |
2.51227 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA2A, ADORA3, ALOX15, APP, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, DYRK1A, EPHX2, FABP3, FABP4, FLT3, HCAR2, IGF1R, KDR, MET, MMP12, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
2.49105 |
[BP] GO:0035588 |
None
|
ADORA1, ADORA2A, ADORA3 |
2.49102 |
[BP] GO:0035809 |
None
|
ADORA2A, AKR1B1, DRD2 |
2.49102 |
[BP] GO:0035813 |
None
|
ADORA1, ADORA2A, DRD2 |
2.49102 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, DRD1, DRD2, MET |
2.47475 |
[BP] GO:0034502 |
protein localization to chromosome
|
AURKB, TERT, TNKS, TNKS2 |
2.46494 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, ADORA2A, DRD1, DRD2 |
2.46494 |
[BP] GO:0002683 |
negative regulation of immune system process
|
ADORA1, ADORA2A, ALOX15, AXL, CYP19A1, DRD2, MMP12, PTPRS |
2.45059 |
[BP] GO:0006909 |
phagocytosis
|
ADORA1, ADORA2A, ALOX15, AXL |
2.44203 |
[BP] GO:1904356 |
regulation of telomere maintenance via telomere lengthening
|
AURKB, SRC, TNKS, TNKS2 |
2.44203 |
[BP] GO:0042749 |
None
|
ADORA1, ADORA2A, DRD2 |
2.43921 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA2A, ADORA3, ALOX15, APP, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1B1, DNMT1, DRD1, DRD2, DYRK1A, EPHX2, FABP3, FABP4, FLT3, HCAR2, IGF1R, KDR, MET, MMP12, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
2.42457 |
[BP] GO:0006810 |
None
|
ABCB1, ACHE, ADORA1, ADORA2A, ALOX15, ALOX5, APP, AXL, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD1, DRD2, FABP3, MMP12, MMP9, PPARA, SRC, TNKS, XDH |
2.40596 |
[BP] GO:0065009 |
regulation of molecular function
|
ABCB1, ADORA1, ADORA2A, ADORA3, APP, AURKB, BCL2, CDC25B, CSNK2A1, CYP1B1, DRD1, DRD2, FABP4, FLT3, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC, TERT, TNKS, XDH |
2.39868 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA2A, ADORA3, APP, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, FABP4, FLT3, IGF1R, MMP9, PTPN1, SRC, TERT, TNKS, XDH |
2.38714 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.38635 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ALOX15, APP, BCL2, CDC25B, DRD2, FLT3, KDR, MMP9, PTPN1, SRC, XDH |
2.36257 |
[BP] GO:0030198 |
extracellular matrix organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.35485 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, DRD1, DRD2 |
2.35449 |
[BP] GO:0051881 |
regulation of mitochondrial membrane potential
|
ADORA2A, BCL2, KDR, SRC |
2.35449 |
[BP] GO:2000573 |
positive regulation of DNA biosynthetic process
|
AURKB, SRC, TNKS, TNKS2 |
2.35449 |
[BP] GO:0043062 |
extracellular structure organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.35356 |
[BP] GO:0040013 |
None
|
ADORA1, ADORA2A, ADORA3, BCL2, CYP19A1, CYP1B1, DRD2 |
2.34752 |
[BP] GO:0044062 |
None
|
ADORA1, ADORA2A, DRD2 |
2.34752 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.34752 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.33915 |
[BP] GO:0002682 |
regulation of immune system process
|
ADORA1, ADORA2A, ALOX15, APP, AXL, BCL2, CA2, CYP19A1, DRD2, HCAR2, MMP12, MMP2, PTPN1, PTPRS, SRC |
2.33185 |
[BP] GO:0051054 |
positive regulation of DNA metabolic process
|
AURKB, DNMT1, IGF1R, SRC, TNKS, TNKS2 |
2.3286 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
ADORA2A, APP, AURKB, DNMT1, DRD1, DRD2, IGF1R, MET, MMP12, PPARA, PTPN1, RORC, SRC, TERT, TNKS, TNKS2 |
2.32847 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADORA2A, APP, AXL, BCL2, CA2, CYP1B1, DRD2, HCAR2, KDR, MET, MMP12, MMP9, PIM1, SRC, TERT |
2.31928 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1 |
2.30509 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.30509 |
[BP] GO:0040014 |
regulation of multicellular organism growth
|
APP, BCL2, DRD2, TNKS2 |
2.30181 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA2A, ADORA3, APP, BCL2, CYP1B1, DRD2, FABP3, TERT, XDH |
2.29937 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.29937 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.29937 |
[BP] GO:0019538 |
protein metabolic process
|
ACHE, ADORA2A, ALPL, APP, AURKB, AXL, BACE1, BCL2, CDC25B, CSNK2A1, DRD1, DYRK1A, FLT3, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, PTPRS, SRC, TNKS, TNKS2 |
2.29604 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, ADORA2A, APP, AURKB, CDC25B, DRD2, FABP4, FLT3, IGF1R, PTPN1, SRC, TNKS |
2.29604 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, FLT3, KDR, PPARA, PTPRS, SRC |
2.28801 |
[BP] GO:0030100 |
regulation of endocytosis
|
ALOX15, APP, AXL, DRD2, PTPN1, SRC |
2.28479 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA2A, ADORA3, APP, AXL, BCL2, CSNK2A1, DRD2, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC, TNKS, TNKS2 |
2.2506 |
[BP] GO:0007416 |
None
|
ACHE, APP, DRD1, DRD2 |
2.24794 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ALOX15, APP, DRD2, FLT3, IGF1R, KDR, PTPN1, SRC, XDH |
2.24358 |
[BP] GO:1904353 |
regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.22773 |
[BP] GO:0001975 |
None
|
ADORA2A, DRD1, DRD2 |
2.22773 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.18658 |
[BP] GO:1904357 |
None
|
SRC, TNKS, TNKS2 |
2.18254 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX15, ALOX5, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD17B1, XDH |
2.14077 |
[BP] GO:0050714 |
None
|
ACHE, ADORA2A, DRD2, HCAR2, MMP12, SRC |
2.1393 |
[BP] GO:0035587 |
None
|
ADORA1, ADORA2A, ADORA3 |
2.13923 |
[BP] GO:0051952 |
None
|
ADORA1, ADORA2A, DRD1, DRD2 |
2.12804 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, MMP2, MMP9, TERT |
2.12804 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
ADORA2A, APP, AURKB, DRD1, DRD2, FABP3, IGF1R, KDR, MET, MMP12, PPARA, RORC, SRC, TERT, TNKS, TNKS2 |
2.12374 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.12043 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.12043 |
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.12043 |
[BP] GO:0071248 |
cellular response to metal ion
|
ALOX15, CYP1A1, CYP1A2, FABP4, MMP9 |
2.1143 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ALOX15, APP, BCL2, CDC25B, CSNK2A1, DNMT1, DRD2, DYRK1A, FLT3, KDR, MMP9, PTPN1, SRC, XDH |
2.10937 |
[BP] GO:0018107 |
peptidyl-threonine phosphorylation
|
BCL2, CSNK2A1, DYRK1A, TNKS |
2.09842 |
[BP] GO:0032204 |
None
|
AURKB, SRC, TNKS, TNKS2 |
2.09842 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD1, DRD2 |
2.09842 |
[BP] GO:0022617 |
extracellular matrix disassembly
|
MMP1, MMP12, MMP2, MMP9 |
2.07999 |
[BP] GO:1903532 |
None
|
ACHE, ADORA2A, CYP19A1, DRD2, HCAR2, MMP12, SRC |
2.0522 |
[BP] GO:0048167 |
None
|
ADORA1, ADORA2A, APP, DRD1, DRD2 |
2.0456 |
[BP] GO:0032963 |
collagen metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.04239 |
[BP] GO:0003018 |
None
|
ADORA1, ADORA2A, DRD1, EPHX2, SRC |
2.03632 |
[BP] GO:0001659 |
None
|
ADORA1, DRD1, DRD2 |
2.03632 |
[BP] GO:0010039 |
response to iron ion
|
BCL2, CYP1A1, DRD2 |
2.03632 |
[BP] GO:0051172 |
None
|
ADORA2A, APP, AURKB, CSNK2A1, DNMT1, DRD2, DYRK1A, FABP4, IGF1R, MMP12, MMP9, PPARA, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
2.01145 |
[CC] GO:0099055 |
None
|
ADORA1, ADORA2A, PTPRS |
3.37515 |
[CC] GO:0099699 |
None
|
ADORA1, ADORA2A, PTPRS |
3.37515 |
[CC] GO:0099240 |
None
|
ADORA1, ADORA2A, PTPRS |
3.37515 |
[CC] GO:0098936 |
None
|
ADORA1, ADORA2A, PTPRS |
3.37515 |
[CC] GO:0005886 |
plasma membrane
|
ABCB1, ACHE, ADORA1, ADORA2A, ADORA3, ALOX15, ALPL, APP, AXL, BACE1, CA12, CA14, CA2, CA4, CA9, CSNK2A1, DRD1, DRD2, FLT3, HCAR2, IGF1R, KDR, MET, MMP2, PIM1, PTPN1, PTPRS, SRC, TERT |
2.6912 |
[CC] GO:0099056 |
None
|
ADORA1, ADORA2A |
2.51704 |
[CC] GO:0098889 |
None
|
ADORA1, ADORA2A |
2.51704 |
[CC] GO:0031253 |
None
|
ADORA1, ADORA2A, CA4, CA9, DRD1, DRD2, SRC |
2.31928 |
[CC] GO:0043226 |
organelle
|
ABCB1, ACHE, ADORA1, ADORA2A, AKR1B1, AKR1B10, ALOX15, ALPL, APP, AURKB, AXL, BACE1, BCL2, CA2, CA4, CA5A, CA5B, CA6, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, DYRK1A, EPHX2, FABP3, FABP4, FLT3, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, PTPRS, RORC, SRC, TERT, TNKS, TNKS2, TUBB3, XDH |
2.25707 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ABCB1, ACHE, ADORA1, AKR1B1, AKR1B10, ALPL, APP, AURKB, AXL, BACE1, BCL2, CA2, CA4, CA5A, CA5B, CA6, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, DYRK1A, EPHX2, FABP3, FABP4, FLT3, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, PTPRS, RORC, SRC, TERT, TNKS, TNKS2, TUBB3, XDH |
2.20224 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA2A, ADORA3, APP, AXL, BACE1, CA4, DRD1, DRD2, FLT3, IGF1R, KDR, MET, PTPRS |
2.00989 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
17.6107 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, ALOX5, APP, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, TNKS, XDH |
13.8376 |
[MF] GO:0043167 |
ion binding
|
ABCB1, ACHE, ALOX15, ALOX5, ALPL, APP, AURKB, AXL, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, DYRK1A, EPHX2, FABP3, FABP4, FLT3, HSD17B1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, PTPRS, RORC, SRC, TERT, TNKS, TNKS2, TUBB3, XDH |
11.9433 |
[MF] GO:0003824 |
catalytic activity
|
ABCB1, ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AURKB, AXL, BACE1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, EPHX2, FLT3, HSD17B1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PTPN1, PTPRS, SRC, TERT, TNKS, TNKS2, TUBB3, XDH |
11.7162 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
11.4412 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
10.1343 |
[MF] GO:0008270 |
zinc ion binding
|
CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, DNMT1, MMP1, MMP12, MMP2, MMP9, PPARA, PTPN1, RORC, TNKS |
7.44082 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALOX5, ALPL, APP, AURKB, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, EPHX2, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, TERT, TNKS, TNKS2, XDH |
6.74504 |
[MF] GO:0016829 |
lyase activity
|
CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
6.67725 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALOX5, ALPL, APP, AURKB, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, EPHX2, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, TERT, TNKS, TNKS2, XDH |
5.17472 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, XDH |
3.82306 |
[MF] GO:0008144 |
drug binding
|
ABCB1, ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DYRK1A, FLT3, IGF1R, KDR, MET, PIM1, PPARA, SRC |
3.82306 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.77772 |
[MF] GO:0001609 |
None
|
ADORA1, ADORA2A, ADORA3 |
3.65385 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.58481 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.53975 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, DYRK1A, FLT3, IGF1R, KDR, MET, SRC |
3.53054 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.13184 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
2.7901 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX15, ALOX5, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD17B1, XDH |
2.74668 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, MET, PIM1, SRC |
2.49789 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, CSNK2A1, FLT3, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SRC |
2.36915 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC |
2.34752 |
[MF] GO:0035586 |
None
|
ADORA1, ADORA2A, ADORA3 |
2.26639 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, CBR1, HSD17B1, XDH |
2.25677 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC |
2.23347 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, ADORA2A, APP, BCL2, CSNK2A1, DRD2, DYRK1A, EPHX2, FLT3, IGF1R, KDR, MET, MMP9, TERT, XDH |
2.0946 |
[MF] GO:0005158 |
None
|
IGF1R, PTPN1, SRC |
2.03632 |